Designing clinical trials to address the needs of childhood and adult asthma: The National Heart, Lung, and Blood Institute's AsthmaNet

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 1, 2014, Pages

  Sutherland, E Rand ^a   Busse, William W ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

asthma; asthma management; AsthmaNet; clinical trials; mechanistic studies; proof of concept; treatment

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; IBUPROFEN; PARACETAMOL; VITAMIN D;

ADD ON THERAPY; ADULT DISEASE; ARTICLE; ASTHMA; CHILDHOOD DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); EXERCISE; HUMAN; LOWER RESPIRATORY TRACT; MICROBIOME; NATIONAL HEALTH ORGANIZATION; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT;

ACETAMINOPHEN VS. IBUPROFEN IN CHILDREN WITH ASTHMA; APRIL; ASTHMA; ASTHMA MANAGEMENT; ASTHMANET; AVICA; AZITHROMYCIN FOR PREVENTING THE DEVELOPMENT OF UPPER RESPIRATORY TRACT ILLNESS INTO LOWER RESPIRATORY TRACT SYMPTOMS IN CHILDREN; BADGER; BARD; BEST ADD-ON THERAPY GIVING EFFECTIVE RESPONSES; BEST AFRICAN-AMERICAN RESPONSE TO ASTHMA DRUGS; CLINICAL TRIALS; DATA COORDINATING CENTER; DCC; ICS; INDIVIDUALIZED THERAPY FOR ASTHMA IN TODDLERS; INFANT; INHALED CORTICOSTEROID; MECHANISTIC STUDIES; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; NATIONAL INSTITUTES OF HEALTH; NHLBI; NIH; OCELOT; ORAL CORTICOSTEROIDS FOR TREATING EPISODES OF SIGNIFICANT LOWER RESPIRATORY TRACT SYMPTOMS IN CHILDREN; PRC; PROOF OF CONCEPT; PROTOCOL REVIEW COMMITTEE; RESPIRATORY TRACT ILLNESS; RTI; SC; STEERING COMMITTEE; STEP-UP YELLOW ZONE INHALED CORTICOSTEROIDS TO PREVENT EXACERBATIONS; STICS; TREATMENT; VIDA; VITAMIN D ADD-ON THERAPY ENHANCES CORTICOSTEROID RESPONSIVENESS IN ASTHMA;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CLINICAL TRIALS AS TOPIC; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); RESEARCH DESIGN; UNITED STATES;

EID: 84891721932     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.10.025     Document Type: Article

References (32)

1. Clinical Centers for the NHLBI Asthma Network (AsthmaNet), RFA-HL-08-010. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-010.html. Accessed June 25, 2013.
2. AsthmaNet Web site. Available at: http://asthmanetresearch.net/. Accessed June 25, 2013.
3. Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet), RFA-HL-08-011. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA- HL-08-011.html. Accessed June 25, 2013.
4. W.W. Busse, W.J. Morgan, V. Taggart, and A. Togias Asthma outcomes workshop: overview J Allergy Clin Immunol 129 Suppl 2012 S1 S8
5. L.C. Denlinger, C.A. Sorkness, V.M. Chinchilli, and R.F. Lemanske Jr. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network J Allergy Clin Immunol 119 2007 3 13
6. S.J. Szefler, V.M. Chinchilli, E. Israel, L.C. Denlinger, R.F. Lemanske Jr., and W. Calhoun et al. Key observations from the NHLBI Asthma Clinical Research Network Thorax 67 2012 450 455
7. R.J. Martin, S.J. Szefler, V.M. Chinchilli, M. Kraft, M. Dolovich, and H.A. Boushey et al. Systemic effect comparisons of six inhaled corticosteroid preparations Am J Respir Crit Care Med 165 2002 1377 1383
8. R.J. Martin, S.J. Szefler, T.S. King, M. Kraft, H.A. Boushey, and V.M. Chinchilli et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial J Allergy Clin Immunol 119 2007 73 80
9. S.J. Szefler, R.J. Martin, T.S. King, H.A. Boushey, R.M. Cherniack, and V.M. Chinchilli et al. Significant variability in response to inhaled corticosteroids for persistent asthma J Allergy Clin Immunol 109 2002 410 418
10. J.M. Drazen, E. Israel, H.A. Boushey, V.M. Chinchilli, J.V. Fahy, and J.E. Fish et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network N Engl J Med 335 1996 841 847
11. E. Israel, V.M. Chinchilli, J.G. Ford, H.A. Boushey, R. Cherniack, and T.J. Craig et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial Lancet 364 2004 1505 1512
12. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske Jr., and C.A. Sorkness et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
13. R.F. Lemanske Jr., C.A. Sorkness, E.A. Mauger, S.C. Lazarus, H.A. Boushey, and J.V. Fahy et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial JAMA 285 2001 2594 2603
14. M.E. Wechsler, S.J. Kunselman, V.M. Chinchilli, E. Bleecker, H.A. Boushey, and W.J. Calhoun et al. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial Lancet 374 2009 1754 1764
15. M.E. Wechsler, E. Lehman, S.C. Lazarus, R.F. Lemanske Jr., H.A. Boushey, and A. Deykin et al. beta-Adrenergic receptor polymorphisms and response to salmeterol Am J Respir Crit Care Med 173 2006 519 526
16. A. Deykin, M.E. Wechsler, H.A. Boushey, V.M. Chinchilli, S.J. Kunselman, and T.J. Craig et al. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma Am J Respir Crit Care Med 175 2007 228 234
17. H.A. Boushey, C.A. Sorkness, T.S. King, S.D. Sullivan, J.V. Fahy, and S.C. Lazarus et al. Daily versus as-needed corticosteroids for mild persistent asthma N Engl J Med 352 2005 1519 1528
18. W.J. Calhoun, B.T. Ameredes, T.S. King, N. Icitovic, E.R. Bleecker, and M. Castro et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial JAMA 308 2012 987 997
19. J.E. Fish, S.P. Peters, C.V. Chambers, S.J. McGeady, K.R. Epstein, and H.A. Boushey et al. An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network Am J Respir Crit Care Med 156 1997 1165 1171
20. S.P. Peters, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, and B.T. Ameredes et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma N Engl J Med 363 2010 1715 1726
21. E.R. Sutherland, T.S. King, N. Icitovic, B.T. Ameredes, E. Bleecker, and H.A. Boushey et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma J Allergy Clin Immunol 126 2010 747 753
22. S.C. Lazarus, V.M. Chinchilli, N.J. Rollings, H.A. Boushey, R. Cherniack, and T.J. Craig et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma Am J Respir Crit Care Med 175 2007 783 790
23. T.W. Guilbert, W.J. Morgan, R.S. Zeiger, D.T. Mauger, S.J. Boehmer, and S.J. Szefler et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma N Engl J Med 354 2006 1985 1997
24. S.J. Szefler, B.R. Phillips, F.D. Martinez, V.M. Chinchilli, R.F. Lemanske, and R.C. Strunk et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 2005 233 242
25. C.A. Sorkness, R.F. Lemanske Jr., D.T. Mauger, S.J. Boehmer, V.M. Chinchilli, and F.D. Martinez et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial J Allergy Clin Immunol 119 2007 64 72
26. L.B. Bacharier, B.R. Phillips, R.S. Zeiger, S.J. Szefler, F.D. Martinez, and R.F. Lemanske Jr. et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing J Allergy Clin Immunol 122 2008 1127 1135.e8
27. R.S. Zeiger, D. Mauger, L.B. Bacharier, T.W. Guilbert, F.D. Martinez, and R.F. Lemanske Jr. et al. Daily or intermittent budesonide in preschool children with recurrent wheezing N Engl J Med 365 2011 1990 2001
28. R.F. Lemanske Jr., D.T. Mauger, C.A. Sorkness, D.J. Jackson, S.J. Boehmer, and F.D. Martinez et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids N Engl J Med 362 2010 975 985
29. R. Strunk, L. Bacharier, B. Phillips, S. Szefler, R. Zeiger, and V. Chinchilli et al. Azithromycin or montelukast as inhaled corticosteroidsparing agents in moderate-to-severe childhood asthma study J Allergy Clin Immunol 122 2008 1138 1144.e4
30. F.D. Martinez, V.M. Chinchilli, W.J. Morgan, S.J. Boehmer, R.F. Lemanske Jr., and D.T. Mauger et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial Lancet 377 2011 650 657
31. F.M. Ducharme, D. Chalut, L. Plotnick, C. Savdie, D. Kudirka, and X. Zhang et al. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers J Pediatr 152 2008 476 480.e1
32. Guidelines for the diagnosis and management of asthma 1997 National Heart, Lung and Blood Institute Bethesda NIH publication no. 07-4051